Stoke Therapeutics Inc buy Canaccord Genuity Group Inc.
Start price
28.04.23
/
50%
€8.85
Target price
28.04.24
€21.78
Performance (%)
28.81%
End price
29.04.24
€11.40
Summary
This prediction ended on 29.04.24 with a price of €11.40. The prediction had a final performance of 28.81%. Canaccord_Genuity_Gr has a follow-up prediction for Stoke Therapeutics Inc where he still thinks Stoke Therapeutics Inc is a Buy. Canaccord_Genuity_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Stoke Therapeutics Inc | -2.554% | -2.554% | 364.812% |
| iShares Core DAX® | 2,29 % | 9,96 % | 14,44 % |
| iShares Nasdaq 100 | 4,54 % | 8,79 % | 40,87 % |
| iShares Nikkei 225® | 2,81 % | 14,08 % | 47,19 % |
| iShares S&P 500 | 3,10 % | 6,85 % | 31,17 % |
Comments by Canaccord_Genuity_Gr for this prediction
In the thread Stoke Therapeutics Inc diskutieren
Stoke Therapeutics, Inc. (NASDAQ: STOK) is now covered by analysts at Canaccord Genuity Group Inc.. They set a "buy" rating and a $24.00 price target on the stock.
Ratings data for STOK provided by MarketBeat
In the thread Trading Stoke Therapeutics Inc
Die von Canaccord_Genuity_Gr gewählte maximale Laufzeit wurde überschritten
Current prediction by Canaccord_Genuity_Gr for Stoke Therapeutics Inc
Stoke Therapeutics Inc
Start price
Target price
Perf. (%)
€28.40
20.03.26
20.03.26
€51.88
20.03.27
20.03.27
9.15%
17.04.26
17.04.26
